Lansoprazole
- Product NDC
- 60687-123
- 11-digit product format
- 606870123
- Labeler code
- 60687
- Product ID
- 60687-123_2b22d4e5-a12d-4e5e-e063-6394a90aa985
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lansoprazole
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA091269
- Marketing category
- ANDA
- Marketing start
- 2016-02-17
- Substance
- LANSOPRAZOLE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lansoprazole
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LANSOPRAZOLE | 30 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0K5C5T2QPG |
| Rxcui | 311277, 596843 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60687-123-01 | Lansoprazole | 100 in 1 BOX, UNIT-DOSE | CAPSULE, DELAYED RELEASE | 100 | | 10 |
| 60687-123-11 | Lansoprazole | 1 in 1 BLISTER PACK | CAPSULE, DELAYED RELEASE | 1 | | 10 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| lansoprazole | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| lansoprazole | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| ammonia | INACTIVE INGREDIENT | 5138Q19F1X | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| ferric oxide yellow | INACTIVE INGREDIENT | EX438O2MRT | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| ferrosoferric oxide | INACTIVE INGREDIENT | XM0M87F357 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| hydroxypropyl cellulose, low substituted | INACTIVE INGREDIENT | 2165RE0K14 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| magnesium carbonate | INACTIVE INGREDIENT | 0E53J927NA | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| methacrylic acid - ethyl acrylate copolymer (1:1) Type A | INACTIVE INGREDIENT | NX76LV5T8J | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| polyethylene glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| raw sugar | INACTIVE INGREDIENT | 8M707QY5GH | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| shellac | INACTIVE INGREDIENT | 46N107B71O | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| starch, corn | INACTIVE INGREDIENT | O8232NY3SJ | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| sucrose | INACTIVE INGREDIENT | C151H8M554 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60687-123 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 10 | Current NDC, Legacy NDC, 2 package rows | 20250109_dee80a19-e514-41e6-9153-c959699d97b1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-123-01 | 60687012301 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-123-01) / 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (60687-123-11) | 100 blister pack | 2016-02-17 | 0000-00-00 | No | No | Current |
| 60687-123-11 | 60687012311 | 1 in 1 BLISTER PACK | | | | | | Historical |